EHMT2 and breast carcinoma: Elevated levels of its expression enhance tumor spread, invasion, cellular proliferation, and movement, resulting in a grim prognosis and decreased overall survival.[40] Kim et al[41] showed that EHMT2 was significantly overexpressed in breast cancer tissues and that EHMT2 knockout reduced tumor cell migration/invasion.